PPP
GSK icon

Private Portfolio Partners’s GSK GSK Stock Holding History

Private Portfolio Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,728
Closed -$203K – 143
2024
Q1 		$203K Buy
+4,728
New +$195K 0.04% 263
2022
Q3 		– Sell
-5,209
Closed -$283K – 273
2022
Q2 		$283K Sell
5,209
-11
-0.2% -$607 0.08% 204
2022
Q1 		$284K Buy
+5,220
New +$284K 0.07% 229

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Private Portfolio Partners's GSK Position: Q2 2024 in Review

Private Portfolio Partners sold out of GSK (GSK) in Q2 2024, closing a stake of 4,728 shares — an estimated $203K sold.

Private Portfolio Partners first reported a position in GSK in Q1 2022 and held it in 3 quarters. The position peaked at $284K in Q1 2022. 884 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

  • Private Portfolio Partners reported no remaining GSK position as of Q2 2024 after selling out during the quarter.
  • Private Portfolio Partners sold 4,728 GSK shares in Q2 2024, an estimated $203K.
  • Private Portfolio Partners first reported a position in GSK in Q1 2022 and held it in 3 quarters.
  • Private Portfolio Partners's GSK position peaked at $284K in Q1 2022.
  • 884 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on Private Portfolio Partners's 13F filing for Q2 2024, filed 15 Aug 2024.